Home/Filings/4/0001415889-23-008914
4//SEC Filing

Dayno Jeffrey M. 4

Accession 0001415889-23-008914

CIK 0001802665other

Filed

May 29, 8:00 PM ET

Accepted

May 30, 4:26 PM ET

Size

5.4 KB

Accession

0001415889-23-008914

Insider Transaction Report

Form 4
Period: 2023-05-26
Dayno Jeffrey M.
DirectorPRESIDENT, CEO
Transactions
  • Award

    Stock Option

    2023-05-26+125,000125,000 total
    Exercise: $35.99Exp: 2033-05-25Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]The stock option vests with respect to 50% of the underlying shares on May 25, 2025, with the remaining shares vesting in twenty-four equal monthly installments beginning on June 25, 2025.

Issuer

Harmony Biosciences Holdings, Inc.

CIK 0001802665

Entity typeother

Related Parties

1
  • filerCIK 0001615993

Filing Metadata

Form type
4
Filed
May 29, 8:00 PM ET
Accepted
May 30, 4:26 PM ET
Size
5.4 KB